Female Pelvic Medicine and Reconstructive Surgery

Journal

Publication Venue For

  • Development of a Simplified Patient-Centered Pelvic Floor Surgery Complication Scale.  28:233-239. 2022
  • Multicenter Randomized Controlled Trial of Pelvic Floor Muscle Training with a Motion-based Digital Therapeutic Device versus Pelvic Floor Muscle Training Alone for Treatment of Stress-predominant Urinary Incontinence.  28:1-6. 2022
  • Design of a Randomized Controlled Trial of Percutaneous Posterior Tibial Nerve Stimulation for the Treatment of Refractory Fecal Incontinence in Women: The NeurOmodulaTion for Accidental Bowel Leakage Study.  27:726-734. 2021
  • Timing and Success of Postoperative Voiding Trial after Colpocleisis with and without Concomitant Midurethral Sling.  27:e608-e613. 2021
  • Comparison of 100 U With 200 U of Intradetrusor OnabotulinumToxinA for Nonneurogenic Urgency Incontinence.  27:140-146. 2021
  • Design of a Randomized Clinical Trial of Perioperative Vaginal Estrogen Versus Placebo With Transvaginal Native Tissue Apical Prolapse Repair (Investigation to Minimize Prolapse Recurrence of the Vagina using Estrogen: IMPROVE).  27:e227-e233. 2021
  • Design of a Study to Measure Patient-Perspectives in Adverse Event Reporting (the PPAR Study): Supplementary Study to the ASPIRe Trial.  27:e112-e117. 2021
  • Do Women Who Self-report More Exercise Have Increased Rates of Symptomatic Stress Urinary Incontinence After Midurethral Slings?.  27:e202-e207. 2021
  • The Design of a Prospective Trial to Evaluate the Role of Preoperative Frailty Assessment in Older Women Undergoing Surgery for the Treatment of Pelvic Organ Prolapse: The FASt Supplemental Trial.  27:e106-e111. 2021
  • Design of a 3-arm randomized trial for posthysterectomy vault prolapse involving sacral colpopexy, transvaginal mesh, and native tissue apical repair: The apical suspension repair for vault prolapse in a three-arm randomized trial.  26:415-424. 2020
  • Diet Modifications in Older Women With Fecal Incontinence: A Qualitative Study.  26:239-243. 2020
  • A 12-Month Clinical Durability of Effectiveness and Safety Evaluation of a Vaginal Bowel Control System for the Nonsurgical Treatment of Fecal Incontinence.  25:113-119. 2019
  • Association of Urinary Phytoestrogens With Pelvic Organ Prolapse and Fecal Incontinence Symptoms in Postmenopausal Women.  25:161-166. 2019
  • Validation and Testing of an E-Learning Module Teaching Core Urinary Incontinence Objectives in a Randomized Controlled Trial.  25:188-192. 2019
  • Anal Sphincter Anatomy Prepregnancy to Postdelivery among the Same Primiparous Women on Dynamic Magnetic Resonance Imaging.  25:22-28. 2019
  • Concomitant Anterior Repair, Preoperative Prolapse Severity, and Anatomic Prolapse Outcomes after Vaginal Apical Procedures.  25:49-55. 2019
  • A review of phytoestrogens and their association with pelvic floor conditions.  24:193-202. 2018
  • Development and Validation of a Quantitative Measure of Adaptive Behaviors in Women with Pelvic Floor Disorders.  23:232-237. 2017
  • Estimation of Uterine Size: How Accurate Are We?.  23:204-207. 2017
  • Irritable bowel syndrome and quality of life in women with fecal incontinence.  23:179-183. 2017
  • Prevalence, Awareness, and Understanding of Pelvic Floor Disorders in Adolescent and Young Women.  22:346-354. 2016
  • Combined Tolterodine and Vaginal Estradiol Cream for Overactive Bladder Symptoms after Randomized Single-Therapy Treatment.  22:254-260. 2016
  • Pelvic Floor Symptoms and Spinal Curvature in Women.  22:219-223. 2016
  • The Design of a Randomized Trial of Vaginal Surgery for Uterovaginal Prolapse: Vaginal Hysterectomy with Native Tissue Vault Suspension Versus Mesh Hysteropexy Suspension (The Study of Uterine Prolapse Procedures Randomized Trial).  22:182-189. 2016
  • Pelvic floor disorders registry: Study design and outcome measures.  22:70-76. 2016
  • Trends and factors influencing inpatient prolapse surgical costs and length of stay in the United States.  22:103-110. 2016
  • Adherence to oral therapy for urgency urinary incontinence: Results from the anticholinergic versus botox comparison (ABC) trial.  22:24-28. 2016
  • The Differential Impact of Flatal Incontinence in Women with Anal Versus Fecal Incontinence.  21:339-342. 2015
  • Incidence and predictors of anal incontinence after obstetric anal sphincter injury in primiparous women.  21:182-189. 2015
  • Medication effects on periurethral sensation and urethral sphincter activity.  21:77-82. 2015
  • Minimum important differences for scales assessing symptom severity and quality of life in patients with fecal incontinence.  20:342-348. 2014
  • What happens to the posterior compartment and bowel symptoms after sacrocolpopexy? Evaluation of 5-year outcomes from E-CARE.  20:261-266. 2014
  • Condition-specific quality of life 24 months after retropubic and transobturator sling surgery for stress urinary incontinence.  18:291-295. 2012
  • Pelvic floor symptoms improve similarly after pessary and behavioral treatment for stress incontinence.  18:118-121. 2012
  • Prolapse symptoms in overweight and obese women before and after weight loss.  18:55-59. 2012
  • Sexual function before and after nonsurgical treatment of stress urinary incontinence.  17:30-35. 2011
  • Summary of research recommendations from the inaugural american urogynecologic society research summit.  17:4-7. 2011
  • Long-term outcomes of the total or supracervical hysterectomy trial.  16:49-57. 2010
  • Systemic effects of vaginally administered estrogen therapy: A review.  16:188-195. 2010
  • International Standard Serial Number (issn)

  • 2151-8378
  • Electronic International Standard Serial Number (eissn)

  • 2154-4212